MET and breast carcinoma: Upon binding of HGF to its receptor MET, it induces the activation of downstream FAK, MAPK, and PI3K/Akt signaling (Birchmeier et al., 2003) and thereby leads to the regulation of a wide range of cellular processes such as metastasis formation in breast cancer cells (Ho‐Yen et al., 2015).